During the forecast period, the nebulizer market size in the Asia-Pacific region is estimated to be growing at a CAGR of 14.2%.
The growth of the APAC nebulizer market is primarily attributed to the factors such as the increasing aging population and growing incidence rate of chronic and respiratory diseases. Rising alcohol consumption, intake of tobacco, and ultra-processed products containing sweetened eatables are the primary cause of the growing prevalence of respiratory infections in Asian countries. Also, the rising number of smokers and environmental pollution is to boost the market growth. Moreover, initiatives such as the regional alliance against chronic diseases develop diagnosis and treatment rates of respiratory disorders, increasing nebulizer market growth. The Cost-effectiveness of the nebulizers is dominating the market growth. The devices that can be charged and used again and electrically powered devices are frequently used devices mushrooming the market demand. The nebulizer market growth is increasing because nebulizers' primary usage is to deliver drugs to the breathing passages, cut down the mucous membrane's swelling caused by pollutants, and activate the thin out the discharge. On the other hand, improving healthcare infrastructure in the emerging countries and rising adoption of portable nebulizers by the patients predominantly offer multiple opportunities in the nebulizers leading market players ensuring market expansion through lucrative opportunities.
However, other nebulization devices have high competition in the market over the period. It is challenging for the new technology or device to gain momentum in the market. The cost of the products is high. Also, a lack of awareness about respiratory diagnosis and treatment impedes the market growth. There are issues raised on respiratory devices' safety profile for infection transmission, diminishing the Asia-Pacific nebulizers market growth.
Impact of COVID-19 APAC Nebulizer Market:
The current outbreak of COVID-19 across the globe has diminished the growth of the economy's different sectors. Pharmaceutical industries have benefited. With the surge in the COVID-19 cases, many countries face a critical shortage of ventilators and inhalers. The demand for the devices has rapidly increased to control the spread of respiratory infection. The frontline doctors and other medical staff are working tirelessly in fighting against the virus among the patients. Moreover, these devices' manufacturing has been partially disrupted due to the stringent government guidelines and unavailability of professionals and workforce declining the market growth. However, the market is expected to increase its share during the forecast period.
The Asia-Pacific Nebulizer Market Research Report has been segmented and sub-segmented into the following categories.
Geographically, the APAC nebulizer market is expected to be the fastest-growing region globally during the forecast period due to a large aging population in developing countries such as China and India, rising interest to promote the regional market. China, India, Japan, and the rest of the APAC are promoting the regional market as it is expected to register a CAGR of 5.1% during the forecast period.
The Chinese market is projected to record the largest share in the APAC Nebulizer market between 2023 to 2028. Significant growth in the applications such as delivery rooms and units. Moreover, rising awareness among the people in this region. However, China is most likely to contribute to the APAC regional market growth with the surge in technologically advanced devices.
The Indian market is predicted to be one of the most lucrative regional markets in the world nebulizer market and estimated to register a healthy CAGR during the forecast period due to the favorable reimbursement scenario, technological innovations, and growing incidences of Asthma.
The Japanese are expected to account substantial share in the APAC market during the forecast period. According to Japan's Ministry of Health, Labour and Welfare, in 2017, it is stated that COPD is the seventh most common cause of death in the region.
KEY MARKET PLAYERS:
Briggs Healthcare, Besco Medical, Ca-Mi, De Vilbiss Healthcare, Feellife Health, Flyp, Invacare, Omron, Philips Respironics, and Pari Medical are some companies playing an important role in the APAC market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]